Detalhe da pesquisa
1.
Lymphangioleiomyomatosis as a potent lung cancer risk factor: Insights from a Japanese large cohort study.
Respirology
; 2024 Apr 23.
Artigo
em Inglês
| MEDLINE | ID: mdl-38654512
2.
Survival past five years with advanced, EGFR-mutated or ALK-rearranged non-small cell lung cancer-is there a "tail plateau" in the survival curve of these patients?
BMC Cancer
; 22(1): 323, 2022 Mar 25.
Artigo
em Inglês
| MEDLINE | ID: mdl-35337281
3.
Association between the efficacy and immune-related adverse events of pembrolizumab and chemotherapy in non-small cell lung cancer patients: a retrospective study.
BMC Cancer
; 22(1): 1047, 2022 Oct 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-36203123
4.
High lymphocyte population-related predictive factors for a long-term response in non-small cell lung cancer patients treated with pemetrexed: a retrospective observational study.
J Transl Med
; 19(1): 92, 2021 02 28.
Artigo
em Inglês
| MEDLINE | ID: mdl-33639962
5.
Preservation of the nipple-areola complex in skin-sparing mastectomy for early breast cancer.
Surg Today
; 48(6): 591-597, 2018 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-29468434
6.
Surfactant protein-D predicts prognosis of interstitial lung disease induced by anticancer agents in advanced lung cancer: a case control study.
BMC Cancer
; 17(1): 302, 2017 05 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-28464801
7.
Oct4 plays a crucial role in the maintenance of gefitinib-resistant lung cancer stem cells.
Biochem Biophys Res Commun
; 473(1): 125-132, 2016 Apr 22.
Artigo
em Inglês
| MEDLINE | ID: mdl-26996130
8.
Cerebral infarction in advanced non-small cell lung cancer: a case control study.
BMC Cancer
; 16: 203, 2016 Mar 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-26964872
9.
Treatment with insulin-like growth factor 1 receptor inhibitor reverses hypoxia-induced epithelial-mesenchymal transition in non-small cell lung cancer.
Biochem Biophys Res Commun
; 455(3-4): 332-8, 2014 Dec 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-25446090
10.
Pemetrexed for advanced non-small cell lung cancer patients with interstitial lung disease.
BMC Cancer
; 14: 508, 2014 Jul 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-25012241
11.
Hyperprogressive disease under anti-PD-1 rechallenge after initial response to anti-PD-1 treatment for non-small cell lung cancer: a case report.
Transl Lung Cancer Res
; 13(3): 666-672, 2024 Mar 29.
Artigo
em Inglês
| MEDLINE | ID: mdl-38601437
12.
MNK1 expression increases during cellular senescence and modulates the subcellular localization of hnRNP A1.
Exp Cell Res
; 318(5): 500-8, 2012 Mar 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-22227431
13.
Association between tooth loss and orodigestive cancer mortality in an 80-year-old community-dwelling Japanese population: a 12-year prospective study.
BMC Public Health
; 13: 814, 2013 Sep 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-24011063
14.
Clinical characteristics of adrenal insufficiency induced by pembrolizumab in non-small-cell lung cancer.
Thorac Cancer
; 14(5): 442-449, 2023 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-36523162
15.
A Retrospective, Multicenter, Observational Study to Evaluate Clinical Outcomes of Lorlatinib After Alectinib in Patients With ALK-Positive NSCLC in Japan.
JTO Clin Res Rep
; 4(5): 100508, 2023 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-37250506
16.
Prognostic value of metabolic tumor burden on 18F-FDG PET in nonsurgical patients with non-small cell lung cancer.
Eur J Nucl Med Mol Imaging
; 39(1): 27-38, 2012 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-21946983
17.
[An analysis of mental disorders of international students visiting the Mental Health Service at Tsukuba University Health Center].
Seishin Shinkeigaku Zasshi
; 114(1): 3-12, 2012.
Artigo
em Japonês
| MEDLINE | ID: mdl-22420147
18.
A Novel Therapeutic Strategy Targeting the Mesenchymal Phenotype of Malignant Pleural Mesothelioma by Suppressing LSD1.
Mol Cancer Res
; 20(1): 127-138, 2022 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-34593606
19.
Impact of the generation of EGFR-TKIs administered as prior therapy on the efficacy of osimertinib in patients with non-small cell lung cancer harboring EGFR T790M mutation.
Thorac Cancer
; 12(3): 329-338, 2021 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-33219754
20.
Phase I study of afatinib plus bevacizumab in patients with advanced non-squamous non-small cell lung cancer harboring EGFR mutations.
Transl Lung Cancer Res
; 10(1): 183-192, 2021 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-33569303